Skip to content

Clinical trials

Recruiting Phase 1/2 Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Status: Recruiting Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20181
20192
20203
20212
20224
20233
20249
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital2
Essen Biotech2
Merck Sharp & Dohme LLC2
National Cancer Institute (NCI)2
AVM Biotechnology Inc1
Affiliated Hospital to Academy of Military Medical Sciences1
AstraZeneca1
Austin I Kim1
Australian & New Zealand Children's Haematology/Oncology Group1
AvenCell Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma43
Lymphoma, Non-Hodgkin11
Leukemia8
Lymphoma, B-Cell7
Lymphoma, Large B-Cell, Diffuse7
Recurrence7
Lymphoma, Follicular6
Neoplasms6
Leukemia, Lymphocytic, Chronic, B-Cell5
Leukemia, Myeloid, Acute5

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.